The company’s shares closed yesterday at $14.92. Samimy covers the Healthcare sector, focusing on stocks such as Jazz Pharmaceuticals, Viking Therapeutics, and Apellis Pharmaceuticals. According to ...

Suvannavejh covers the Healthcare sector, focusing on stocks such as Axsome Therapeutics, Apellis Pharmaceuticals, and Corbus Pharmaceuticals. Neumora Therapeutics, Inc. has an analyst consensus of ...

Apellis Pharmaceuticals APLS is gearing up ... on the analyst ratings and average 1-year price targets of Amicus Therapeutics, Iovance Biotherapeutics and Rhythm Pharmaceuticals, three prominent ...

In this comparison, we explore the analyst ratings and average 1-year price targets of Iovance Biotherapeutics, Apellis Pharmaceuticals and Amicus Therapeutics, three prominent industry players ...

Dr Arshad Khanani reports on several compelling talks given at the neovascular AMD session at AAO 2024. Dr Barbara Blodi presented higher rates of macular atrophy in patients treated with anti ...

Stoke Therapeutics, Inc. (STOK) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.55 per share a year ago.

Live webcasts of the presentations will be available via the Events & Presentations page in the Investors section of ADC Therapeutics' website, ir.adctherapeutics.com. A replay of each webcast ...

Peer Ratings Comparison In this comparison, we explore the analyst ratings and average 1-year price targets of Iovance Biotherapeutics, Apellis Pharmaceuticals and Amicus Therapeutics, three ...

Live webcasts of the presentations will be available via the Events & Presentations page in the Investors section of ADC Therapeutics' website, ir.adctherapeutics.com. A replay of each webcast will be ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company ...